Prof Karin Hing
PhD, BSc, CEng, MIMMM, FHEA, FRSA, FWES

Current Funding

RAEng Research Chair Sept 2024 KA Hing
Karin Hing
£209,059
28-04-2025 - 27-04-2030
3D perfusion bioreactor studentship Baxter - EPSRC DTP CASE Conversion 2021
Karin Hing
£30,000 Baxter Healthcare Corporation
21-09-2021 - 20-09-2025
Sponsorship of P/T Student: Daniel Johnson
Karin Hing
£128,992 Apatech Ltd
01-02-2011 - 01-08-2026

KTP AKT (QMUL-Lucideon) - Radio Opaque Cements and Osteoclast Testing: Traceable Bio-Remodellable Cements
Karin Hing and Simon Rawlinson
£41,283 Innovate UK
25-03-2024 - 24-07-2024
KTP with Lucideon: Cell testing to assist development of novel biomaterials
Karin Hing and Simon Rawlinson
£256,237 Innovate UK
17-02-2021 - 17-02-2024
Bioresorbable bioactive composites Kick off
Karin Hing and Emiliano Bilotti
£50,243 Baxter Healthcare Corporation
11-01-2021 - 22-01-2025
Bioactive bioresorbable composites for load bearing guided bone regeneration
Karin Hing
£29,000 Baxter Healthcare Corporation
01-10-2020 - 30-09-2024
Development of mechanically enhanced osteoinductive synthetic bone graft substitutes
Karin Hing
£87,500 Apatech Ltd
01-10-2017 - 31-03-2022
Doctoral Educational Research Agreement
Karin Hing
£79,714 Baxter Healthcare Corporation
01-01-2015 - 31-03-2022